EdgarLookup
10-Q/A

10-Q/A

Company
Stoke Therapeutics, Inc.
Filed
May 14, 2021
Period of Report
March 31, 2021
Accession Number
0001193125-21-161309
View Document ↗ View on SEC.gov ↗